Is 24h nicotine equivalents a surrogate for smoke exposure based on its relationship with other biomarkers of exposure?

Reference

• Baker RR, Dixon M. (2006). The retention of tobacco smoke constituents in the human respiratory tract. Inhalation Toxicology 18(4):255–294.
   Google Scholar
• Benowitz NL, Jacob P III, Yu L, Talcott R, Hall S, Jones RT. (1986). Reduced tar, nicotine, and carbon monoxide exposure while smoking ultralow-but not low-yield cigarettes. The Journal of the American Medical Association 256(2):241–246.
   Google Scholar
• Benowitz NL, Jacob P. III. (2001). Trans-3′-hydroxycotinine: disposition kinetics, effects and plasma levels during cigarette smoking. British Journal Clinical Pharmacology 51.1:53–59.
   Google Scholar
• Benowitz NL, Swan GE, Jacob P III, Lessov-Schlaggar CN, Tyndale RF. (2006). CYP2A6 genotype and the metabolism and disposition kinetics of nicotine. Clininal Pharmacology & Therapeutics 80.5:457–67.
   Google Scholar
• Bombick DW, Bombick BR, Ayres PH, Putnam K, Avalos J, Borgerding MF, Doolittle DJ. (1997). Evaluation of the genotoxic and cytotoxic potential of mainstream whole smoke and smoke condensate from a cigarette containing a novel carbon filter. Fundamental and Applied Toxicology 39:11–17.
   PubMedGoogle Scholar
• Brown PJ, Benard LL, Reid KR, Petsikas D, Massey TE. (2007). Analysis of CYP2A contributions to metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human peripheral lung microsomes. Drug Metabolism and Disposition 35.11:2086–94.
   Google Scholar
• Chepiga TA, Morton MJ, Murphy PA, Avalos JT, Bombick BR, Doolittle DJ, Borgerding MF, Swauger JE. (2000). A comparison of the mainstream smoke chemistry and mutagenicity of a representative sample of the US cigarette market with two Kentucky reference cigarettes (K1R4F and K1R5F). Food and Chemical Toxicology 38:949–962.
   PubMed Web of Science ®Google Scholar
• Dougherty D, Garte S, Barchowsky A, Zmuda J, Taioli E. (2008). NQO1, MPO, CYP2E1, GSTT1 and GSTM1 polymorphisms and biological effects of benzene exposure–a literature review. Toxicology Letters 182:7–17.
   PubMed Web of Science ®Google Scholar
• Feng S, Roethig HJ, Liang Q, Kinser R, Jin Y, Scherer G, Urban M, Engl J, Riedel K. (2006). Evaluation of urinary 1-hydroxypyrene, S-phenylmercapturic acid, trans,trans-muconic acid, 3-methyladenine, 3-ethyladenine, 8-hydroxy-2′-deoxyguanosine and thioethers as biomarkers of exposure to cigarette smoke. Biomarkers 11:28–52.
   PubMed Web of Science ®Google Scholar
• Feng S, Plunkett SE, Lam K, Kapur S, Muhammad R, Jin Y, Zimmermann M, Mendes P, Kinser R, Roethig HJ. (2007a). A new method for estimating the retention of selected smoke constituents in the respiratory tract of smokers during cigarette smoking. Inhalation Toxicology 19.2:169–79.
   Google Scholar
• Feng S, Kapur S, Sarkar M, Muhammad R, Mendes P, Newland K, Roethig HJ. (2007b). Respiratory retention of nicotine and urinary excretion of nicotine and its five major metabolites in adult male smokers. Toxicology Letters 173:101–106.
   PubMed Web of Science ®Google Scholar
• Frost-Pineda K, Zedler BK, Oliveri D, Liang Q, Feng S, Roethig HJ. (2008a). 12-Week clinical exposure evaluation of a third-generation electrically heated cigarette smoking system (EHCSS) in adult smokers. Regulatory Toxicology and Pharmacology 52(2):111–117.
   Google Scholar
• Frost-Pineda K, Zedler BK, Oliveri D, Feng S, Liang Q, Roethig HJ. (2008b). Short-term clinical exposure evaluation of a third-generation electrically heated cigarette smoking system (EHCSS) in adult smokers. Regulatory Toxicology Pharmacology 52(2):104–110.
   Google Scholar
• Fustinoni S, Soleo L, Warholm M, Begemann P, Rannug A, Neumann HG, Swenberg J, Vimercati L, Foà V, Colombi A. (2002). Influence of metabolic genotypes on biomarkers of exposure to 1,3-butadiene in humans. Cancer Epidemiology, Biomarkers and Prevention 11:1082–90.
   PubMed Web of Science ®Google Scholar
• Gallagher CJ, Muscat JE, Hicks AN, Zheng Y, Dyer A-M, Chase GA, Richie J, Lazarus P. (2007). The UDP-glucuronosyltransferase 2B17 gene deletion polymorphism: sex-specific association with urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol glucuronidation phenotype and risk for lung cancer. Cancer Epidemiology, Biomarkers & Prevention 16.4:823–28.
   Google Scholar
• Goniewicz ML, Havel CM, Peng MW, Jacob P 3rd, Dempsey D, Yu L, Zielinska-Danch W, Koszowski B, Czogala J, Sobczak A, Benowitz NL. (2009). Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol. Cancer Epidemiology, Biomarkers & Prevention 18(12):3421–5.
   Google Scholar
• Hatsukami DK, Benowitz NL, Rennard SI, Oncken C, Hecht SS. (2006). Biomarkers to assess the utility of potential reduced exposure tobacco products. Nicotine & Tobacco Research 8:600–622.
   PubMed Web of Science ®Google Scholar
• Hecht SS, Carmella SG, Murphy SE, Akerkar S, Brunnemann KD, Hoffmann D. (1993). A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. The New England Journal of Medicine 329:1543–1546.
   PubMed Web of Science ®Google Scholar
• Hecht SS. (2002). Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis 23(6):907–922.
   Google Scholar
• Institute of Medicine. (2001). Clearing the smoke: assessing the science base for tobacco harm reduction. Stratton K, Shetty P, Wallace R, Bondurant S, editors. Washington, D.C., USA: National Academy Press.
   Google Scholar
• International Conference on Harmonization (ICH). (1996). Tripartite Guideline for Good Clinical Practice. In: International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Clinical Use.
   Google Scholar
• Joseph AM, Hecht SS, Murphy SE, Carmella SG, Le CT, Zhang Y, Han S, Hatsukami DK. (2005). Relationships between cigarette consumption and biomarkers of tobacco toxin exposure. Cancer Epidemiology, Biomarkers & Prevention 14(12):2963–2968.
   Google Scholar
• Kensler CJ, Battista SP. (1963). Components of cigarette smoke with ciliary-depressant activity, their selective removal by filters containing activated charcoal granules. The New England Journal of Medicine 269:1161–1166.
   PubMed Web of Science ®Google Scholar
• Mascher DG, Mascher HJ, Scherer G, Schmid ER. (2001). High-performance liquid chromatographic-tandem mass spectrometric determination of 3-hydroxypropylmercapturic acid in human urine. Journal of Chromatography B: Biomedical Sciences and Applications 750:163–169.
   PubMed Web of Science ®Google Scholar
• Mendes P, Kapur S, Wang J, Feng S, Roethig H. (2008). A randomized, controlled exposure study in adult smokers of full flavor Marlboro cigarettes switching to Marlboro Lights or Marlboro Ultra Lights cigarettes. Regulatory Toxicology and Pharmacology 51:295–305.
   PubMed Web of Science ®Google Scholar
• Mendes PE, Liang Q, Frost-Pineda K, Munjal S, Roethig HJ, Walk RA. (2009). The relationship between smoking machine derived tar yields and biomarkers of exposure in adult cigarette smokers in the U.S. Regulatory Toxicology and Pharmacology 55(1):17–27. [Epub ahead of print]. doi: 10.1016/j.yrtph.2009.05.016.
   Google Scholar
• Patterson F, Benowitz N, Shields P, Kaufmann V, Jepson C, Wileyto P, Kucharski S, Lerman C. (2003). Individual differences in nicotine intake per cigarette. Cancer Epidemiology, Biomarkers & Prevention 12.5:468–71.
   Google Scholar
• Pillsbury HC, Bright CC, O’Connor KJ, Irish FW. (1969). Tar and nicotine in cigarette smoke. Journal of the Association of Official Analytical Chemists 52:458–462.
   Google Scholar
• Qu Q, Melikian AA, Li G, Shore R, Chen L, Cohen B, Yin S, Kagan MR, Li H, Meng H, Jin X, Winnik W, Li Y, Mu R, Li K. (2000). Validation of biomarkers in humans exposed to benzene: urine metabolites. American Journal of Industrial Medicine 37:522–531.
   PubMed Web of Science ®Google Scholar
• Rodgman A, Smith CJ, Perfetti TA. (2000). The composition of cigarette smoke: a retrospective, with emphasis on polycyclic components. Human & Experimental Toxicology 19:573–595.
   PubMed Web of Science ®Google Scholar
• Roethig HJ, Kinser RD, Lau RW, Walk RA, Wang N. (2005). Short-term exposure evaluation of adult smokers switching from conventional to first-generation electrically heated cigarettes during controlled smoking. Journal of Clinical Pharmacology 45.2:133–45.
   Google Scholar
• Roethig HJ, Zedler BK, Kinser RD, Feng S, Nelson BL, Liang Q. (2007). Short-term clinical exposure evaluation of a second-generation electrically heated cigarette smoking system. Journal of Clinical Pharmacology 47:518–530.
   PubMed Web of Science ®Google Scholar
• Roethig HJ, Feng S, Liang Q, Liu J, Rees WA, Zedler BK. (2008). A 12-month, randomized, controlled study to evaluate exposure and cardiovascular risk factors in adult smokers switching from conventional cigarettes to a second-generation electrically heated cigarette smoking system. Journal of clinical pharmacology 48(5):580–91
   Google Scholar
• Roethig HJ, Munjal S, Feng S, Liang Q, Sarkar M, Walk RA, Mendes PE. (2009). Population estimates for biomarkers of exposure to selected cigarette smoke constituents of adult U.S. cigarette smokers. Nicotine & Tobacco Research 11(10):1216–1225.
   Google Scholar
• Sarkar M, Kapur S, Frost-Pineda K, Feng S, Wang J, Liang Q, Roethig H. (2008). Evaluation of biomarkers of exposure to selected cigarette smoke constituents in adult smokers switched to carbon filtered cigarettes in short term and long term clinical studies. Nicotine & Tobacco Research 10(12):1761–1772.
   Google Scholar
• Scherer G. (1999). Smoking behaviour and compensation: a review of the literature. Psychopharmacology 145:1–20.
   PubMed Web of Science ®Google Scholar
• Scherer G, Frank S, Riedel K, Meger-Kossien I, Renner T. (2000). Biomonitoring of exposure to polycyclic aromatic hydrocarbons of nonoccupationally exposed persons. Cancer Epidemiology, Biomarkers & Prevention 9:373–380.
   PubMed Web of Science ®Google Scholar
• Scherer G. (2005). Biomonitoring of inhaled complex mixtures–ambient air, diesel exhaust and cigarette smoke. Experimental Toxicology and Pathology 57(Suppl. 1):75–110.
   Google Scholar
• Scherer G, Engl J, Urban M, Gilch G, Janket D, Riedel K. (2007). Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany. Regulatory Toxicology and Pharmacology 47(2):171–83.
   Google Scholar
• Smith CJ, Perfetti TA, Rumple MA, Rodgman A, Doolittle DJ. (2000). “IARC group 2A Carcinogens” reported in cigarette mainstream smoke. Food and Chemical Toxicology 38:371–383.
   PubMed Web of Science ®Google Scholar
• Smith CJ, Perfetti TA, Rumple MA, Rodgman A, Doolittle DJ. (2001). “IARC Group 2B carcinogens” reported in cigarette mainstream smoke. Food and Chemical Toxicology 39:183–205.
   PubMedGoogle Scholar
• St. Charles FK, Krautter GR, Dixon M, Mariner DC. (2006). A comparison of nicotine dose estimates in smokers between filter analysis, salivary cotinine, and urinary excretion of nicotine metabolites. Psychopharmacology 189:345–354.
   PubMed Web of Science ®Google Scholar
• Swan GE, Habina K, Means B, Jobe JB, Esposito JL. (1993). Saliva cotinine and recent smoking–evidence for a nonlinear relationship. Public Health Report 108(6):779–783.
   PubMedGoogle Scholar
• Van Iersel ML, Ploemen JP, Lo Bello M, Federici G, van Bladeren PJ. (1997). Interactions of alpha, beta-unsaturated aldehydes and ketones with human glutathione S-transferase P1-1. Chemico-Biological Interaction 108(1-2):67–78.
   Google Scholar
• Whitehead T, Metayer C, Ward MH, Nishioka MG, Gunier R, Colt JS, Reynolds P, Selvin S, Buffler P, Rappaport SM. (2009). Is house-dust nicotine a good surrogate for household smoking? American Journal of Epidemiology 169:1113–1123.
   Google Scholar
• World Health Organization (WHO) technical report series No. 951. (2008). The scientific basis of tobacco product regulation: second report of a WHO study group.
   Google Scholar
• World Medical Association. (2000). Declaration of Helsinki ethical principles for medical research involving human subjects. In: 52nd WMA General Assembly. Edinburg, Scotland.
   Google Scholar
• Zacny JP, Stitzer ML. (1988). Cigarette brand-switching: effects on smoke exposure and smoking behavior. The Journal of Pharmacology and Experimental Therapeutics. 246(2):619–27.
   PubMedGoogle Scholar
• Zedler BK, Kinser R, Oey J, Nelson B, Roethig HJ, Walk RA, Kuhl P, Rustemeier K, Schepers G, Von Holt K, Tricker AR. (2006). Biomarkers of exposure and potential harm in adult smokers of 3–7 mg tar yield (Federal Trade Commission) cigarettes and in adult non-smokers. Biomarkers 11(3):201–220.
   Google Scholar